2 Stocks Under $50 on Our Watchlist and 1 We Find Risky
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to volatility as many lack the scale advantages of their larger peers.
This is precisely where StockStory comes in - we do the heavy lifting to identify companies with solid fundamentals so you can invest with confidence. That said, here are two stocks under $50 with massive upside potential and one that may have trouble.
One Stock Under $50 to Sell:
Progyny (PGNY)
Share Price: $24.06
Pioneering a data-driven approach to family building that has achieved an industry-leading patient satisfaction score of +80, Progyny (NASDAQ:PGNY) provides comprehensive fertility and family building benefits solutions to employers, helping employees access quality fertility treatments and support services.
Why Do We Think Twice About PGNY?
- Subscale operations are evident in its revenue base of $1.27 billion, meaning it has fewer distribution channels than its larger rivals
- Low returns on capital reflect management’s struggle to allocate funds effectively
Progyny’s stock price of $24.06 implies a valuation ratio of 13x forward P/E. Read our free research report to see why you should think twice about including PGNY in your portfolio.
Two Stocks Under $50 to Watch:
Oscar Health (OSCR)
Share Price: $16.81
Founded in 2012 to simplify the notoriously complex American healthcare system, Oscar Health (NYSE:OSCR) is a technology-focused health insurance company that offers individual and small group health plans through its cloud-native platform.
Why Will OSCR Outperform?
- Annual revenue growth of 39.7% over the last two years was superb and indicates its market share increased during this cycle
- Earnings per share grew by 30.3% annually over the last four years and trumped its peers
- Free cash flow margin increased by 12.8 percentage points over the last five years, giving the company more capital to invest or return to shareholders
At $16.81 per share, Oscar Health trades at 0.4x forward price-to-sales. Is now the right time to buy? See for yourself in our full research report, it’s free for active Edge members.
Amalgamated Financial (AMAL)
Share Price: $30.96
Founded in 1923 by labor unions seeking a financial institution aligned with worker values, Amalgamated Financial (NASDAQGM:AMAL) operates a values-oriented bank that provides commercial banking, trust services, and investment management to socially responsible organizations and individuals.
Why Are We Fans of AMAL?
- Net interest margin expanded by 16.3 basis points (100 basis points = 1 percentage point) over the last two years, providing additional flexibility for investments
- Share repurchases have amplified shareholder returns as its annual earnings per share growth of 18% exceeded its revenue gains over the last five years
- Annual tangible book value per share growth of 20.5% over the last two years was superb and indicates its capital strength increased during this cycle
Amalgamated Financial is trading at $30.96 per share, or 1.2x forward P/B. Is now a good time to buy? Find out in our full research report, it’s free for active Edge members.
Stocks We Like Even More
If your portfolio success hinges on just 4 stocks, your wealth is built on fragile ground. You have a small window to secure high-quality assets before the market widens and these prices disappear.
Don’t wait for the next volatility shock. Check out our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today for free. Find your next big winner with StockStory today. Find your next big winner with StockStory today
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.